T. Rowe Price Associates »

Larimar Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Larimar Therapeutics (LRMR) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Larimar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Larimar Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Larimar Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $89k 14k 6.61
2024-06-30 $98k 14k 7.28

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Nvidia Corporation Comm Stk (NVDA)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Unitedhealth Group Comm Stk (UNH)
Alphabet Comm Stk (GOOG)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Netflix Comm Stk (NFLX)
Tesla Comm Stk (TSLA)
Intuitive Surgical Comm Stk (ISRG)
Thermo Fisher Scientific Comm Stk (TMO)

View all positions for T. Rowe Price Associates

Top funds holding Larimar Therapeutics

Deerfield Management Company
RA Capital Management
Henderson Group
Goldman Sachs Group
Blue Owl Capital Holdings
BlackRock
BlackRock
Vanguard Group
Verition Fund Management
Driehaus Capital Management
Woodline Partners
State Street Corporation
Geode Capital Management
Altium Capital Management
Fred Alger Management

View all funds holding Larimar Therapeutics